10 Best European Stocks To Buy According to Billionaires

5. AstraZeneca PLC (NASDAQ:AZN)

Number of Billionaires: 14

AstraZeneca PLC (NASDAQ:AZN) is a British-Swedish multinational pharmaceutical and biotechnology company headquartered in Cambridge, UK. The company specializes in developing and manufacturing prescription medicines, primarily for oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation areas. AstraZeneca’s diverse portfolio includes leading products such as Tagrisso, Imfinzi, and Lynparza in oncology and Symbicort in respiratory care. AZN is among the best European stocks according to billionaires.

In 2024, AstraZeneca PLC (NASDAQ:AZN) reported a 21% increase in revenue, reaching $54.1 billion, driven by strong performance in its oncology segment. Despite challenges in China, its second-largest market, the company offset a 3% sales decline there with growth in other regions. CEO Pascal Soriot projects a “catalyst-rich period” ahead, aiming for $80 billion in revenue by 2030, with a high single-digit revenue increase expected for 2025.

In 2025, AstraZeneca (NASDAQ:AZN) continues to show strong momentum, with its 50-day moving average and 21-day exponential moving average trending upward. The stock has gained nearly 17% since the start of the year, significantly outperforming the broader market. On March 13, the stock closed at $75.57, up 1.79%, and has risen 2.08% over the past month, outpacing the Medical sector’s decline of 1.05%. Analysts project earnings per share (EPS) of $1.10, marking a 6.8% increase from the previous year. Analysts remain bullish, with 88% of 33 analysts giving a Buy rating and a strong revenue base of $54.1 billion reinforcing its long-term growth potential.